BioMab Inc
@biomabinc.com
BioMab discovers and develops cutting edge immune-based diagnostics and therapeutics to enable healthcare professionals provide patients with personalized care.
BioMab Inc's Company Logos
BioMab Inc's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FFC000
Amber
255, 192, 0
45, 100, 50
0, 25, 100, 0
#FFCC33
Sunglow
255, 204, 51
45, 100, 60
0, 20, 80, 0
#045184
Venice Blue
4, 81, 132
204, 94, 27
97, 39, 0, 48
About BioMab Inc
BioMab Inc. We specialize in discovering and developing cutting-edge immune-based diagnostics and therapeutics, revolutionizing cancer diagnosis and treatment. Our current product portfolio focuses on two primary areas of precision medicine: circulating tumor cells (CTC) and companion diagnostics (CDx).
Our flagship product is a Positive CTC Selection Assay, a breakthrough technology that can detect cancer through a simple blood draw. This non-invasive method, also known as Liquid Biopsy, has the potential to transform cancer diagnosis and treatment. Additionally, we offer immune-based companion diagnostics that work in conjunction with targeted therapies, such as antibody drugs and immunotherapies.
With a strong focus on research and development, we collaborate with leading companies to develop innovative products and maximize the success rates of new drug candidates in clinical trials. By leveraging our expertise in antibodies and biology, we are continuously expanding our reagents/diagnostics pipelines to target various cancers and infectious diseases. Join us in our mission to provide personalized care and improve healthcare outcomes.
Contact us to learn more about our groundbreaking products and services
